Ella Stimson, Delaney Shea, Michelle M. Gomes, Srivathsan Ranganathan, Sarah Mitchell, Jason Ware, Randall Armstrong, Christian Ross, Michael Heller, Stuart D. Ibsen
{"title":"Utilizing Two Electrokinetic Techniques on a Single Device for Detection of Extracellular Vesicle-Associated Protease Activity","authors":"Ella Stimson, Delaney Shea, Michelle M. Gomes, Srivathsan Ranganathan, Sarah Mitchell, Jason Ware, Randall Armstrong, Christian Ross, Michael Heller, Stuart D. Ibsen","doi":"10.1002/smll.202404457","DOIUrl":null,"url":null,"abstract":"Protease activity is an emerging biomarker for cancer detection as activity levels are often increased in tumor tissue compared to healthy tissue. Of particular interest is the activity of proteases carried by extracellular vesicle (EV) nanoparticles which are oversecreted by tumors into circulation. Current methods to analyze the activity of proteases bound to EVs require complex multi-instrument sample processing to separate EVs from plasma to quantify protease activity. This makes EV-based protease activity detection a challenge for diagnostic or point-of-care applications. Here, a method is reported that manipulates EV nanoparticles and charged molecular byproducts from protease activity using two different electrokinetic phenomena generated by a single electrode microarray within a microfluidic channel. Dielectrophoresis is first generated to recover EVs carrying active trypsin-like proteases from human plasma followed by electrophoresis for subsequent analysis of peptide cleavage products indicating protease activity. This method demonstrates signal amplification through protease catalytic activity in combination with concentrating mechanisms of dielectrophoresis and electrophoresis. Using this approach, a significant difference in protease activity is observed between patients with pancreatic cancer and benign cysts. This demonstrates dual-electrokinetic chip-based technology as a useful tool to manipulate different sized and charged analytes in a single device enabling future clinical translation of EV-based protease diagnostics.","PeriodicalId":228,"journal":{"name":"Small","volume":"170 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Small","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1002/smll.202404457","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Protease activity is an emerging biomarker for cancer detection as activity levels are often increased in tumor tissue compared to healthy tissue. Of particular interest is the activity of proteases carried by extracellular vesicle (EV) nanoparticles which are oversecreted by tumors into circulation. Current methods to analyze the activity of proteases bound to EVs require complex multi-instrument sample processing to separate EVs from plasma to quantify protease activity. This makes EV-based protease activity detection a challenge for diagnostic or point-of-care applications. Here, a method is reported that manipulates EV nanoparticles and charged molecular byproducts from protease activity using two different electrokinetic phenomena generated by a single electrode microarray within a microfluidic channel. Dielectrophoresis is first generated to recover EVs carrying active trypsin-like proteases from human plasma followed by electrophoresis for subsequent analysis of peptide cleavage products indicating protease activity. This method demonstrates signal amplification through protease catalytic activity in combination with concentrating mechanisms of dielectrophoresis and electrophoresis. Using this approach, a significant difference in protease activity is observed between patients with pancreatic cancer and benign cysts. This demonstrates dual-electrokinetic chip-based technology as a useful tool to manipulate different sized and charged analytes in a single device enabling future clinical translation of EV-based protease diagnostics.
蛋白酶活性是一种新兴的癌症检测生物标志物,因为与健康组织相比,肿瘤组织中的蛋白酶活性水平通常会升高。尤其令人感兴趣的是由细胞外囊泡 (EV) 纳米颗粒携带的蛋白酶活性,这些颗粒由肿瘤分泌进入血液循环。目前分析与EV结合的蛋白酶活性的方法需要复杂的多仪器样本处理,以便从血浆中分离出EV来量化蛋白酶活性。这使得基于 EV 的蛋白酶活性检测成为诊断或护理点应用的一项挑战。本文报告了一种方法,该方法利用微流体通道内单个电极微阵列产生的两种不同电动现象来处理 EV 纳米粒子和蛋白酶活性产生的带电分子副产物。首先产生压电效应,从人体血浆中回收携带活性胰蛋白酶样蛋白酶的 EV,然后进行电泳,对表明蛋白酶活性的肽裂解产物进行后续分析。这种方法结合了介电泳和电泳的浓缩机制,通过蛋白酶催化活性实现了信号放大。利用这种方法,可以观察到胰腺癌患者和良性囊肿患者的蛋白酶活性存在显著差异。这证明基于芯片的双电动力学技术是一种有用的工具,可在单个设备中操纵不同大小和带电的分析物,使基于 EV 的蛋白酶诊断技术在未来实现临床转化。
期刊介绍:
Small serves as an exceptional platform for both experimental and theoretical studies in fundamental and applied interdisciplinary research at the nano- and microscale. The journal offers a compelling mix of peer-reviewed Research Articles, Reviews, Perspectives, and Comments.
With a remarkable 2022 Journal Impact Factor of 13.3 (Journal Citation Reports from Clarivate Analytics, 2023), Small remains among the top multidisciplinary journals, covering a wide range of topics at the interface of materials science, chemistry, physics, engineering, medicine, and biology.
Small's readership includes biochemists, biologists, biomedical scientists, chemists, engineers, information technologists, materials scientists, physicists, and theoreticians alike.